A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer

NCT00102219 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Pemetrexed
DRUG: Doxorubicin

Sponsor

Eli Lilly and Company